Physician

Akira Yamamoto, MD

According to 2025 Medicare claims, Akira Yamamoto, MD (NPI: 1669769386) practices urology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 19047-1752. Yamamoto is affiliated with the WellSpan Population Health Services (ACO ID: A2500), Trinity Health Integrated Care (ACO ID: A3454), and Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Yamamoto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 898 traditional Medicare patients, billed 19,111 HCPCS/CPT codes, and received $334,414 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,363 prescription claims across 843 beneficiaries totaling $656,028 in drug costs, led by Xtandi (Enzalutamide). DME data shows 21 claims. Open Payments data shows 1 records totaling $73. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $32,411 to $334,414. Similarly, Part D prescription costs have moved sharply higher in recent years, from $320 to $656,028. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,308 to $484.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	116	655	$32,411
2017	463	4,627	$183,712
2018	585	7,150	$209,954
2019	665	16,962	$315,271
2020	662	21,504	$377,652
2021	768	25,846	$348,817
2022	812	25,789	$381,051
2023	870	21,938	$343,224
2024	898	19,111	$334,414

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	20	37	$320
2016	60	146	$11,486
2017	186	674	$44,148
2018	250	886	$65,243
2019	296	1,066	$91,607
2020	464	1,686	$336,299
2021	574	2,341	$517,623
2022	649	2,661	$521,509
2023	701	2,754	$467,297
2024	843	3,363	$656,028

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	64	$10,410
2020	N/R	34	$8,940
2021	N/R	38	$10,091
2022	N/R	41	$10,262
2023	N/R	27	$11,229
2024	N/R	21	$11,382

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	504	948	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	228	283	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	119	171	$62
51798	Ultrasound measurement of bladder capacity after voiding	461	612	$8
81003	Automated urinalysis test	474	685	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	16	480	$231,506
Myrbetriq	Mirabegron	270	13,749	$200,748
Gemtesa	Vibegron	25	1,350	$20,704
Tamsulosin Hcl	Tamsulosin Hcl	1,036	75,732	$16,452
Finasteride	Finasteride	634	52,089	$11,199

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	21	$11,382

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$73	Myriad Genetic Laboratories, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Akira Yamamoto, MD?

Tedicare shows public-source Medicare data for Akira Yamamoto, MD (NPI 1669769386), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akira Yamamoto, MD have ACO affiliation data?

Akira Yamamoto, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500), Trinity Health Integrated Care (MSSP, ACO ID A3454), and Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Akira Yamamoto, MD?

Akira Yamamoto, MD is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Akira Yamamoto, MD have Open Payments data?

Akira Yamamoto, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.